AMYOTROPHIC LATERAL SCLEROSIS – PATHOGENESIS, CLINICAL FEATURES, AND DIAGNOSTIC STRATEGIES

Authors

  • Khakimov M.N. Author

Keywords:

Keywords: amyotrophic lateral sclerosis, ALS, motor neuron disease, TDP-43, SOD1, C9orf72, excitotoxicity, neurodegeneration.

Abstract

Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder characterized by the selective degeneration of upper and lower motor neurons in the brain and spinal cord. The disease leads to progressive muscle weakness, atrophy, paralysis, and ultimately respiratory failure. This article reviews current knowledge regarding the molecular mechanisms, genetic factors, clinical manifestations, and diagnostic approaches to ALS.

References

1. Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nature Reviews Disease Primers. 2017;3:17071.

2. Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197–206.

3. Brown RH Jr, Al-Chalabi A. Amyotrophic lateral sclerosis. New England Journal of Medicine. 2017;377(2):162–172.

4. Renton AE, Chio A, Traynor BJ. State of play in ALS genetics. Nature Neuroscience. 2014;17(1):17–23.

5. Gendron TF, Petrucelli L. Neurodegeneration: ALS genetics. Nature Reviews Neurology. 2011;7(11):617–618.

Published

2025-12-10

How to Cite

Khakimov M.N. (2025). AMYOTROPHIC LATERAL SCLEROSIS – PATHOGENESIS, CLINICAL FEATURES, AND DIAGNOSTIC STRATEGIES. JOURNAL OF NEW CENTURY INNOVATIONS, 90(2), 92-93. https://journalss.org/index.php/new/article/view/9275